<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="366314">
  <stage>Registered</stage>
  <submitdate>13/05/2014</submitdate>
  <approvaldate>28/05/2014</approvaldate>
  <actrnumber>ACTRN12614000570684</actrnumber>
  <trial_identification>
    <studytitle>The effect of citalopram versus a placebo on central auditory processing in the elderly.</studytitle>
    <scientifictitle>The effect of citalopram versus a placebo on central auditory processing in the elderly.</scientifictitle>
    <utrn>U1111-1156-7707</utrn>
    <trialacronym>citalopram_cap</trialacronym>
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Hearing Loss</healthcondition>
    <conditioncode>
      <conditioncode1>Ear</conditioncode1>
      <conditioncode2>Deafness</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>citalopram 20 mg/day, in oral capsule, for 6 months;
Medical consultation every 2 months for drug delivery. At same time, the adherence will be evaluated as well as collateral effects or even other clinical benefits from the drug.</interventions>
    <comparator>placebo (starch pills) /day, in oral capsule, for 6 months.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Improvement in Central Auditory Test (Pitch Pattern sequence, Dichotic Digit Test)

</outcome>
      <timepoint>06 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Patients handicap will be evaluated by Hearing Handicap Inventory for Elderly test (HHIE)</outcome>
      <timepoint>06 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Cognitive status will be evaluated by Minimental Cognitive Test</outcome>
      <timepoint>06 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Tinnitus will be evaluated by Tinnitus Handicap Inventory</outcome>
      <timepoint>06 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Depression and humor status will be Beck Depression Inventory</outcome>
      <timepoint>06 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Subjects with hearing threshold from normal to moderate loss and with low performance in central auditory processes tests.</inclusivecriteria>
    <inclusiveminage>60</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Contraindications for the drug (citalopram). </exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>central randomisation by computer</concealment>
    <sequence>Simple randomisation using a randomisation table created by computer</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>False</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/07/2014</anticipatedstartdate>
    <actualstartdate>19/10/2015</actualstartdate>
    <anticipatedenddate />
    <actualenddate>15/01/2016</actualenddate>
    <samplesize>60</samplesize>
    <actualsamplesize>49</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>15/08/2016</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state>Sao Paulo</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Jose Fernando Polanski</primarysponsorname>
    <primarysponsoraddress>Centro do Deficiente Auditivo - Federal University of Sao Paulo
Borges Lagoa street, number 783 - 2nd. floor 
Vila Clementino - Sao Paulo - Sao Paulo
postal code 04038-031</primarysponsoraddress>
    <primarysponsorcountry>Brazil</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Elderly with 60 years or more, with hearing impairment detected and confirmed by poor performance in Central Auditory Processing tests. 
60 Subjects will be divided into two groups and given citalopram 20 mg/day or placebo for 6 months. Hearing evaluation will be performed initially and after 6 months and will include pure-tone audiometry, speech discrimination test (SDT), emittanciometry, hearing handicap inventory for elderly test (HHIE), minimental cognitive test and Central Auditory Processing evaluation. </summary>
    <trialwebsite />
    <publication>Serotonin reuptake inhibitors in auditory processing disorders in elderly patients: preliminary results. Cruz OL, Kasse CA, Sanchez M, Barbosa F, Barros FA. Laryngoscope. 2004;114(9):1656-9.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Comite de Etica em Pesquisa - Unifesp/ hospital Sao Paulo</ethicname>
      <ethicaddress>Botucatu street, number 572, 1st floor
Zip code 04023-061 
Sao Paulo - Sao Paulo</ethicaddress>
      <ethicapprovaldate>1/02/2013</ethicapprovaldate>
      <hrec>CAAE 11299413.5.0000.5505</hrec>
      <ethicsubmitdate />
      <ethiccountry>Brazil</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Jose Fernando Polanski</name>
      <address>Centro do Deficiente Auditivo - Federal University of Sao Paulo
Borges Lagoa street, number 783 - 2nd floor 
Vila Clementino - Sao Paulo - SP
postal code 04038-031</address>
      <phone>+55 11 5576 4848 add 2427</phone>
      <fax />
      <email>jfpolanski@gmail.com</email>
      <country>Brazil</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Jose Fernando Polanski</name>
      <address>Centro do Deficiente Auditivo - Federal University of Sao Paulo
Borges Lagoa street, number 783 - 2nd floor 
Vila Clementino - Sao Paulo - SP
postal code 04038-031</address>
      <phone>+55 11 5576 4848 add 2427</phone>
      <fax />
      <email>jfpolanski@gmail.com</email>
      <country>Brazil</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Jose Fernando Polanski</name>
      <address>Centro do Deficiente Auditivo - Federal University of Sao Paulo
Borges Lagoa street, number 783 - 2nd floor 
Vila Clementino - Sao Paulo - SP
postal code 04038-031</address>
      <phone>+55 11 5576 4848 add 2427</phone>
      <fax />
      <email>jfpolanski@gmail.com</email>
      <country>Brazil</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>